Cardiac and skeletal myopathies: can genotype explain phenotype?

Area of Science:

• Genetics and Molecular Biology
• Cardiovascular Diseases
• Neuromuscular Disorders

Background:

• Inherited muscle diseases, such as nemaline myopathy and hypertrophic cardiomyopathy (HCM), are well-established genetic disorders.
• Recent research indicates that mutations in nearly any sarcomeric protein can result in myopathy, suggesting a common phenotype from diverse genetic changes.
• Conversely, evidence now shows that mutations in a single sarcomeric protein can manifest as different muscle disease phenotypes.

Purpose of the Study:

• To explore the complex relationship between sarcomeric protein mutations and the resulting muscle disease phenotypes.
• To highlight the phenomenon where a single gene mutation can lead to varied clinical presentations in inherited muscle disorders.

Main Methods:

• Review of recent scientific literature and case studies.
• Analysis of genetic mutations in sarcomeric proteins and their associated clinical phenotypes.
• Comparative analysis of disease presentation based on specific protein involvement.

Main Results:

• Mutations in various sarcomeric protein components can indeed cause myopathies.
• A single sarcomeric protein mutation can lead to distinct muscle disease phenotypes.
• Actin mutations exemplify this, being linked to hypertrophic cardiomyopathy, dilated cardiomyopathy, nemaline myopathy, and actin myopathy.

Conclusions:

• The genotype-phenotype correlation in inherited muscle diseases is complex and not always straightforward.
• Sarcomeric protein mutations represent a significant genetic basis for a spectrum of muscle disorders.
• Further research into actin and other sarcomeric proteins is crucial for understanding disease mechanisms and developing targeted therapies.